AMADEO, ELISABETH
 Distribuzione geografica
Continente #
NA - Nord America 1.072
AS - Asia 512
EU - Europa 460
SA - Sud America 73
Continente sconosciuto - Info sul continente non disponibili 45
AF - Africa 8
OC - Oceania 1
Totale 2.171
Nazione #
US - Stati Uniti d'America 1.046
RU - Federazione Russa 294
SG - Singapore 211
CN - Cina 121
BD - Bangladesh 64
BR - Brasile 63
IT - Italia 61
VN - Vietnam 38
HK - Hong Kong 33
FR - Francia 23
DE - Germania 22
GB - Regno Unito 21
IN - India 16
CA - Canada 14
JP - Giappone 9
PL - Polonia 6
FI - Finlandia 5
MX - Messico 5
NL - Olanda 5
ES - Italia 4
LT - Lituania 4
SE - Svezia 4
AT - Austria 3
ID - Indonesia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BE - Belgio 2
BO - Bolivia 2
HN - Honduras 2
IQ - Iraq 2
MA - Marocco 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
PK - Pakistan 2
SV - El Salvador 2
TR - Turchia 2
ZA - Sudafrica 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
MD - Moldavia 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.126
Città #
Dallas 736
Singapore 148
Moscow 56
Ashburn 44
Hong Kong 33
Beijing 30
New York 28
San Jose 25
Los Angeles 19
Santa Clara 17
Ho Chi Minh City 16
Lauterbourg 13
Munich 12
Council Bluffs 10
Milan 10
Hanoi 9
Orem 9
São Paulo 9
Tokyo 9
Hefei 8
London 8
Montreal 7
Poplar 7
Chicago 6
Cesano Boscone 5
Chennai 5
North Bergen 5
Rome 5
Secaucus 5
Shanghai 5
Warsaw 5
Brooklyn 4
Denver 4
Guangzhou 4
Manchester 4
Newark 4
Phoenix 4
Stockholm 4
Boardman 3
Frankfurt am Main 3
Houston 3
Mumbai 3
Naples 3
Tianjin 3
West Palm Beach 3
Amsterdam 2
Atlanta 2
Bari 2
Belo Horizonte 2
Biên Hòa 2
Boston 2
Brescia 2
Brussels 2
Buffalo 2
Charlotte 2
Chengdu 2
Cleveland 2
Dhaka 2
Duque de Caxias 2
Fortaleza 2
Helena 2
Helsinki 2
Ipoh 2
Islington 2
Jinhua 2
Johannesburg 2
Lappeenranta 2
Managua 2
Mexico City 2
Milwaukee 2
Monza 2
Nuremberg 2
Oklahoma City 2
Orlando 2
Pelotas 2
Phủ Lý 2
Querétaro 2
Rio de Janeiro 2
San Salvador 2
Santa Fe 2
São José dos Campos 2
Washington 2
Adel 1
Agadir 1
Alexandria 1
Alto Paraguai 1
Amstelveen 1
Anchorage 1
Ann Arbor 1
Annapolis 1
Antakya 1
Avaré 1
Avellino 1
Balneário Gaivota 1
Bangkok 1
Barranquilla 1
Batesville 1
Belford Roxo 1
Belgrade 1
Bishkek 1
Totale 1.445
Nome #
Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab 437
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study 422
Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma 148
Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study 141
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab 135
Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents 122
Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab 115
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 111
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients 109
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma 98
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab 89
Past, present, and future of FGFR inhibitors in cholangiocarcinoma: from biological mechanisms to clinical applications 83
Anti-HER2 therapies in biliary tract cancers: A meta-analysis on disease location, HER2 status, and survival outcomes 81
Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients 80
Totale 2.171
Categoria #
all - tutte 4.650
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.650


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 0 0 1 6 5
2024/2025104 6 0 0 3 8 10 11 16 5 5 4 36
2025/20261.972 98 374 461 158 125 51 61 109 270 57 110 98
2026/202783 47 36 0 0 0 0 0 0 0 0 0 0
Totale 2.171